Home Other Building Blocks 478-94-4
478-94-4,MFCD01716210
Catalog No.:AA006YKL

478-94-4 | 9,10-Didehydro-6-methylergoline-8beta-carboxamide

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA006YKL
Chemical Name:
9,10-Didehydro-6-methylergoline-8beta-carboxamide
CAS Number:
478-94-4
Molecular Formula:
C16H17N3O
Molecular Weight:
267.3257
MDL Number:
MFCD01716210
SMILES:
CN1C[C@@H](C=C2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N
Properties
Computed Properties
 
Complexity:
461  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
1.6  

Literature

Title: Analysis of lysergic acid amide in human serum and urine after ingestion of Argyreia nervosa seeds.

Journal: Analytical and bioanalytical chemistry 20120801

Title: Variable adverse effects in subjects after ingestion of equal doses of Argyreia nervosa seeds.

Journal: Forensic science international 20120110

Title: Problem child is no headache.

Journal: Headache 20110201

Title: Two cases of lysergamide intoxication by ingestion of seeds from Hawaiian Baby Woodrose.

Journal: Forensic science international 20100415

Title: Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Journal: Neurocritical care 20080101

Title: Novel ergopeptides as dual ligands for adenosine and dopamine receptors.

Journal: Journal of medicinal chemistry 20070628

Title: [Voluntary intoxication by D-lysergic acid amide (LSA) in a 15-year-old teenager via Internet: new fact of society].

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20060801

Title: Hydrolysis of lysergamide to lysergic acid by Rhodococcus equi A4.

Journal: Journal of biotechnology 20011117

Title: [Pathomorphologic changes in the brain during long-term combined administration of lysergamide (LSD-25) and haloperidol (experimental morphologic study) s].

Journal: Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952) 19710101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:478-94-4 Molecular Formula|478-94-4 MDL|478-94-4 SMILES|478-94-4 9,10-Didehydro-6-methylergoline-8beta-carboxamide